Use of a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof

Details for Australian Patent Application No. 2004305325 (hide)

Owner Pronova Biocare AS

Inventors Kopecky, Jan; Bryhn, Morten

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004305325

PCT Pub. Number WO2005/060954

Priority 0303513-6 19.12.03 SE; 60/530,644 19.12.03 US

Filing date 17 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 7 February 2008

International Classifications

A23L 1/30 (2006.01) Foods or foodstuffs - containing additives

A61K 31/202 (2006.01)

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/060954 Priority application(s): WO2005/060954

7 February 2008 Application Accepted

  Published as AU-B-2004305325

22 May 2008 Alteration of Name

  The name of the applicant has been altered to Pronova BioPharma Norge AS 2005

5 June 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305337-Use of IL-6 in the preparation of pharmaceutical compositions for treating and preventing liver injury

2004305321-Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity